Delivery Order SPE2DB20D1100-SPE2DB25FC9U9
- Not listed
- The Defense Logistics Agency awarded a $1,727.54 delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Epinephrine 0.3 mg auto-injector 2-packs. This is a firm fixed price, non-set-aside contract with a completion date of September 24, 2025, and will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Epinephrine 0.3 mg auto-inject auto-injectors (2-pack). This $4,480.59 firm fixed-price delivery order, with an ultimate completion date of September 17, 2025, represents a child contract under AmerisourceBergen's broader indefinite delivery contract with DLA Troop Support Medical (SPE2DX), a $999.9 billion prime vehicle running through December 2026. No set-aside...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on June 16, 2025, for the supply of Epinephrine 0.3 mg auto-injector packs valued at $2,954.20. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of June 17, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award represents a single delivery order issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $24.5K delivery order to AmerisourceBergen Drug Corp on May 12, 2025, for the supply of Epinephrine 0.3 mg auto-injector (2-pack). This competitively awarded, firm fixed-price delivery order has an ultimate completion date of May 13, 2025, and will be fulfilled at the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract action issued under AmerisourceBergen's larger Indefinite Delivery Contract vehicle with...
- The Defense Logistics Agency awarded a $3,626.12 delivery order to AmerisourceBergen Drug Corp on June 20, 2025, for the supply of Epinephrine 0.3 mg auto-injector two-packs, with completion scheduled for June 23, 2025. The contract utilizes firm fixed pricing with no set-aside designation, indicating competitive procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under...
- The Defense Logistics Agency awarded a $1,987.16 delivery order to AmerisourceBergen Drug Corp for the supply of Epinephrine 0.3 mg auto-injector (2-pack) on July 25, 2025, with an ultimate completion date of July 28, 2025. This firm fixed price delivery order represents a non-set-aside, competitively awarded contract with performance taking place at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The contract leverages AmerisourceBergen's Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of Epinephrine 0.15 mg auto-injectors in a two-pack configuration. This contract, valued at $11,352.44, represents a firm fixed-price delivery order under a non-set-aside competitive procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of epinephrine 0.3 mg auto-injector 2-packs with a ceiling value of $8,428.38. This firm fixed-price delivery order, which is non-competitive and carries an ultimate completion date of September 16, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Epinephrine 0.3 mg auto-injector two-packs under a firm fixed-price contract valued at $23,359.12. The order was competitively awarded without set-aside designation and is scheduled for completion by July 23, 2025. Performance will be conducted at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $2,418.48 on August 5, 2025, for the supply of Epinephrine 0.3 mg auto-injector 2-packs. This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 6, 2025. The award will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract issued under...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FC9U9Delivery Order
The Defense Logistics Agency awarded a $24,754.55 delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of Epinephrine 0.3 mg auto-injectors (2-pack units). This is a firm fixed-price, non-set-aside contract with a completion date of June 20, 2025, and performance to be fulfilled at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. The delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive $999.99 billion pharmaceutical support vehicle running through December 2026 that enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, has established itself as a critical vendor for federal medical procurement through competitive awards with the Defense Logistics Agency. The company's extensive contract portfolio with DLA demonstrates its capability to fulfill diverse medical supply requirements, including specialty medications, vaccines, medical devices, and auto-injector systems across multiple therapeutic domains. This delivery order for epinephrine auto-injectors supports the Defense Health Agency and broader military healthcare systems requiring emergency pharmaceutical supplies for anaphylaxis treatment.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $24.8k | 6/18/25 |